SL Science Holding

SLBT · NASDAQ

$1.15−$0.16 (−12.21%)TodayMarket closed ·
Prev close $1.31

Latest news

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • Press releaseGlobe Newswire

    SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant Glioblastoma

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsAvi Kapoor

    NetApp, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

  • NewsAvi Kapoor

    Why Snowflake Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket

  • Press releaseGlobe Newswire

    SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company

  • News

    SL Science Highlighted The Filing Of A New Drug Master File With The U.S. FDA Covering Exosomes Derived From Gamma Delta T Cells

  • Press releaseGlobe Newswire

    SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform

  • Press releaseGlobe Newswire

    SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releaseGlobe Newswire

    SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology

  • NewsAvi Kapoor

    Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

  • Press releaseGlobe Newswire

    SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma

  • NewsAvi Kapoor

    Nike, Shutterstock And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

  • Press releaseGlobe Newswire

    SL Science Holding Limited Reports Full Year 2025 Financial Results

  • NewsAvi Kapoor

    Why Smith & Wesson Brands Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Crude Oil Edges Higher; US Retail Sales Top Estimates

  • NewsAvi Kapoor

    US Stocks Edge Higher; CarMax Posts Upbeat Earnings

  • Press releaseGlobe Newswire

    Biotech Bulls Stampede as Clinical Wins and Milestones Fuel Momentum

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.